Your browser doesn't support javascript.
loading
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.
Fenizia, Claudio; Moltrasio, Chiara; Ottobrini, Luisa; Utyro, Olga; Genovese, Giovanni; Vanetti, Claudia; Trabattoni, Daria; Marzano, Angelo V.
Afiliação
  • Fenizia C; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy. Electronic address: claudio.fenizia@unimi.it.
  • Moltrasio C; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Ottobrini L; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Utyro O; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  • Genovese G; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Vanetti C; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  • Trabattoni D; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  • Marzano AV; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
J Invest Dermatol ; 143(8): 1601-1604, 2023 08.
Article em En | MEDLINE | ID: mdl-36716924

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pênfigo / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pênfigo / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article